US 11352435
Anti-CD133 monoclonal antibodies and related compositions and methods
granted A61KA61K2039/505A61P
Quick answer
US patent 11352435 (Anti-CD133 monoclonal antibodies and related compositions and methods) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00